Docetaxel in Treating Children With Recurrent Solid Tumors

Clinical trial NCT00002825 · COMPLETED

Trial details

NCT number: NCT00002825
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors Neuroblastoma Sarcoma

Start date: 1997-01-01
Primary completion: 2004-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.